Prostate Cancer - Results from #27620

Variable prostate-specific antigen management patterns by nonurologist providers at a tertiary care medical center - Abstract July 1, 2011

Preoperative characteristics of men with unfavorable high-Gleason prostate cancer at radical prostatectomy - Abstract July 1, 2011

Redefining high-risk prostate cancer based on distant metastases and mortality after high-dose radiotherapy with androgen deprivation therapy - Abstract July 1, 2011

Palliative radiotherapy for bone metastases in the last 3 months of life: Worthwhile or futile? - Abstract July 1, 2011

Predictors for response to intermittent androgen deprivation (IAD) in prostate cancer cases with biochemical progression after surgery - Abstract July 1, 2011

Concordance of preoperative prostate endorectal MRI with subsequent prostatectomy specimen in high-risk prostate cancer patients - Abstract July 1, 2011

Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers - Abstract July 1, 2011

Comorbidity, use of common medications, and risk of early death in patients with localized or locally advanced prostate cancer - Abstract July 1, 2011

Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: A nested case-control study - Abstract July 1, 2011

Costs of early adjuvant radiation therapy after radical prostatectomy: A decision analysis - Abstract June 30, 2011

New therapies for castrate-resistant prostate cancer - Abstract June 30, 2011

Efficacy of a referral and physical activity program for survivors of prostate cancer [ENGAGE]: Rationale and design for a cluster randomised controlled trial - Abstract June 30, 2011

Increased accumulation of paclitaxel and doxorubicin in proliferating capillary cells and prostate cancer cells following ultrasound exposure - Abstract June 30, 2011

Mortality among men with locally advanced prostate cancer managed with noncurative intent: A nationwide study in PCBaSe Sweden - Abstract June 30, 2011

The benefits of including clinical factors in rectal normal tissue complication probability modeling after radiotherapy for prostate cancer - Abstract June 30, 2011

Distant metastases following permanent interstitial brachytherapy for patients with clinically localized prostate cancer - Abstract June 30, 2011

Influence of antiflatulent dietary advice on intrafraction motion for prostate cancer radiotherapy - Abstract June 30, 2011

Comparison of prophylactic naftopidil, tamsulosin, and silodosin for (125)I brachytherapy-induced lower urinary tract symptoms in patients with prostate cancer: Randomized controlled trial - Abstract June 30, 2011

Comparative toxicity and dosimetric profile of whole-pelvis versus prostate bed-only intensity-modulated radiation therapy after prostatectomy - Abstract June 30, 2011

Sanguinarine suppresses prostate tumor growth and inhibits survivin expression - Abstract June 30, 2011

Page 1382 of 1438